Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000629187 | SCV000750103 | uncertain significance | Chédiak-Higashi syndrome | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 2936 of the LYST protein (p.Val2936Ile). This variant is present in population databases (rs2753327, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with LYST-related conditions. ClinVar contains an entry for this variant (Variation ID: 525145). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LYST protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000658240 | SCV000780011 | uncertain significance | not provided | 2023-06-06 | criteria provided, single submitter | clinical testing | Observed in a patient with primary platelet secretion defect; this individual also harbored variants in other possible causative genes (Gorski et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30819905, 18485661, 27535533) |
Fulgent Genetics, |
RCV000629187 | SCV000894771 | uncertain significance | Chédiak-Higashi syndrome | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000629187 | SCV001256311 | uncertain significance | Chédiak-Higashi syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Center for Genomics, |
RCV000629187 | SCV002495830 | uncertain significance | Chédiak-Higashi syndrome | 2021-05-11 | criteria provided, single submitter | clinical testing | LYST NM_000081.3 exon 35 p.Val2936Ile (c.8806G>A): This variant has not been reported in the literature but is present in 0.08% (57/68026) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-235731173-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:525145). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Genome Diagnostics Laboratory, |
RCV002263841 | SCV002543673 | uncertain significance | Autoinflammatory syndrome | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002528824 | SCV003549375 | uncertain significance | Inborn genetic diseases | 2021-06-06 | criteria provided, single submitter | clinical testing | (Gorski, 2019; Leinoe, 2017) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000629187 | SCV003815320 | uncertain significance | Chédiak-Higashi syndrome | 2019-11-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000658240 | SCV004033008 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | LYST: BP4 |